Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily

Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily

Author: Pharma and BioTech News September 2, 2026 Duration: 5:15
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into the dynamic landscape of the industry, highlighting significant scientific breakthroughs, strategic partnerships, and regulatory updates that are reshaping healthcare as we know it. Novartis recently announced a major milestone with its BTK inhibitor, Rhapsido, which met its Phase 3 clinical trial goals for treating relapsing multiple sclero...

Every morning, the world of life sciences shifts with new clinical data, strategic deals, and regulatory decisions. Keeping pace with it all is a full-time job. Pharma and BioTech Daily is designed to be that essential, efficient briefing for professionals and investors who need the signal through the noise. This daily podcast delivers a concise, human-curated audio update that synthesizes the most critical developments from the previous day. You’ll hear clear summaries of pipeline milestones, merger and acquisition activity, policy changes, and corporate strategy shifts-all contextualized for their real-world impact. The production leverages AI tools to monitor vast data streams, but each episode is carefully supervised and narrated by editors to ensure accuracy and relevance. It’s for anyone who builds companies in this space, manages portfolios, or makes strategic decisions where science meets business. Tune in for a focused, factual, and time-saving digest that fits into your morning routine, brought to you by the team at Pharma and BioTech News and produced by the boutique studio OWITH.ai. This isn't about lengthy interviews or opinion; it's a streamlined tool to inform your day in the complex, fast-moving pharma and biotech landscape.
Author: Language: en-us Episodes: 50

Pharma and BioTech Daily
Podcast Episodes
Biogen Acquires Apellis for Growth | Pharma and Biotech Daily [not-audio_url] [/not-audio_url]

Duration: 5:00
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Biogen has made a significant acquisition by purchasing Apellis Pharmaceuticals, a move…
AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily [not-audio_url] [/not-audio_url]

Duration: 4:31
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a wealth of significant advancements and strategic moves shapi…
Scribe Therapeutics Raises $129M in IPO | Pharma and Biotech Daily [not-audio_url] [/not-audio_url]

Duration: 5:20
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into the latest groundbreaking advancements, strategic corporate ma…
Repligen Buys BioLife for $1.5B | Pharma and Biotech Daily [not-audio_url] [/not-audio_url]

Duration: 5:06
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're delving into a series of significant breakthroughs and strategic moves res…